IL128382A - Method for reducing viruses - Google Patents

Method for reducing viruses

Info

Publication number
IL128382A
IL128382A IL12838298A IL12838298A IL128382A IL 128382 A IL128382 A IL 128382A IL 12838298 A IL12838298 A IL 12838298A IL 12838298 A IL12838298 A IL 12838298A IL 128382 A IL128382 A IL 128382A
Authority
IL
Israel
Prior art keywords
virus
variants
brain
mrpr
membrane receptor
Prior art date
Application number
IL12838298A
Other languages
English (en)
Hebrew (he)
Other versions
IL128382A0 (en
Inventor
Alan Barret
Kate Ryman
Haolin Ni
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/874,272 external-priority patent/US6010894A/en
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Publication of IL128382A0 publication Critical patent/IL128382A0/xx
Publication of IL128382A publication Critical patent/IL128382A/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL12838298A 1997-06-13 1998-06-08 Method for reducing viruses IL128382A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/874,272 US6010894A (en) 1997-06-13 1997-06-13 Method of screening for attenuating viruses
US9098298A 1998-06-05 1998-06-05
PCT/US1998/011329 WO1998056896A1 (en) 1997-06-13 1998-06-08 Method of attenuating viruses

Publications (2)

Publication Number Publication Date
IL128382A0 IL128382A0 (en) 2000-01-31
IL128382A true IL128382A (en) 2001-12-23

Family

ID=26782846

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12838298A IL128382A (en) 1997-06-13 1998-06-08 Method for reducing viruses

Country Status (8)

Country Link
EP (1) EP0922092B1 (de)
JP (1) JP2002514088A (de)
CN (1) CN1229434A (de)
AT (1) ATE274574T1 (de)
CA (1) CA2263993A1 (de)
DE (1) DE69825847D1 (de)
IL (1) IL128382A (de)
NZ (1) NZ333990A (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103289966B (zh) * 2013-07-03 2014-11-05 青岛易邦生物工程有限公司 一种猪乙型脑炎病毒弱毒株
EP3031923A1 (de) * 2014-12-11 2016-06-15 Institut Pasteur Lentivirale, vektorbasierte immunogene Zusammensetzung gegen Japanische Enzephalitis

Also Published As

Publication number Publication date
JP2002514088A (ja) 2002-05-14
NZ333990A (en) 2000-10-27
ATE274574T1 (de) 2004-09-15
EP0922092A1 (de) 1999-06-16
CN1229434A (zh) 1999-09-22
DE69825847D1 (de) 2004-09-30
IL128382A0 (en) 2000-01-31
EP0922092A4 (de) 2001-09-19
EP0922092B1 (de) 2004-08-25
CA2263993A1 (en) 1998-12-17

Similar Documents

Publication Publication Date Title
AU2009241354B2 (en) Chimeric West Nile/Dengue viruses
Monath et al. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax™) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates
KR101074175B1 (ko) 플라비바이러스 백신
CN109069615B (zh) 在儿童和年轻人中针对登革热病毒接种疫苗的组合物和方法
Ni et al. Attenuation of Japanese encephalitis virus by selection of its mouse brain membrane receptor preparation escape variants
CN111778263B (zh) 用于疫苗中的登革热病毒嵌合式构建物的组合物及方法
KR101150584B1 (ko) 웨스트 나일 바이러스 백신
Pletnev Infectious cDNA clone of attenuated Langat tick-borne flavivirus (strain E5) and a 3′ deletion mutant constructed from it exhibit decreased neuroinvasiveness in immunodeficient mice
RU2208635C2 (ru) Днк-конструкт жизнеспособного химерного рекомбинантного флавивируса, вакцина против вируса клещевого энцефалита, способ предотвращения инфицирования млекопитающего вирусом клещевого энцефалита
Mcminn et al. Murray valley encephalitis virus envelope protein antigenic variants with altered hemagglutination properties and reduced neuroinvasiveness in mice
JP2007525226A (ja) フラビウイルスワクチン
Serafin et al. Identification of epitopes on the envelope (E) protein of dengue 2 and dengue 3 viruses using monoclonal antibodies
Gao et al. Classification of a new member of the TBE flavivirus subgroup by its immunological, pathogenetic and molecular characteristics: identification of subgroup-specific pentapeptides
AU730660B2 (en) Method of attenuating viruses
Ishak et al. Comparative sequences of two type 1 dengue virus strains possessing different growth characteristics in vitro
EP0922092B1 (de) Verfahren zur abschwächung von viren
CN101084010B (zh) 抗日本脑炎病毒及西尼罗病毒的疫苗
CN100412089C (zh) 蜱传黄病毒的全长感染性cDNA克隆
KR20000068161A (ko) 바이러스를 약독화시키는 방법
HK1106723B (en) Vaccines against japanese encephalitis virus and west nile virus
HK1106723A1 (en) Vaccines against japanese encephalitis virus and west nile virus
HK1194432A (en) Flavivirus vaccines
HK1194432B (en) Flavivirus vaccines

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees